Trevena
TRVN
$0.37
Share price
5.17%
Change (1 day)
-43.91%
Change (1 year)
Categories
Earnings for Trevena (TRVN)
Earnings in 2023 (TTM): -$28.16 M
According to Trevena's latest financial reports the company's current earnings (TTM) are -$28.16 M. In 2022 the company made an earning of -$52.42 M a decrease over its 2021 earnings that were of -$51.71 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Trevena from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$28.16 M | -46.28% |
| 2022 | -$52.42 M | 1.38% |
| 2021 | -$51.71 M | 78.04% |
| 2020 | -$29.04 M | 21.3% |
| 2019 | -$23.94 M | -13.91% |
| 2018 | -$27.81 M | -59.75% |
| 2017 | -$69.09 M | -31.77% |
| 2016 | -$0.11 B | 101.73% |
| 2015 | -$50.2 M | 1.14% |
| 2014 | -$49.64 M | 114.83% |
| 2013 | -$23.11 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $7.85 B | -27,996.16% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -10,878.46% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -$79.39 M | 181.94% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$0.53 B | 1,768.90% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | -$10.29 M | -63.47% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -$0.12 B | 318.74% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -$0.63 B | 2,126.45% | 🇺🇸 USA |